Security Flaws Found in Azure Health Bot Serviceby Lilu Anderson 13.08.2024Researchers discover vulnerabilities in Azure's AI Health Bot, raising security concerns for sensitive data access.
PDS Biotech’s Q2 2024 Update: Clinical Progressby Lilu Anderson 13.08.2024PDS Biotech aligns with FDA for Phase 3 trial, reports Q2 2024 financials with reduced net loss and expenses.
AI Predicted to Boost Returns in Biotech Stocksby Lilu Anderson 13.08.2024AI integration in biotech could reduce R&D costs, enhance efficiency, and increase returns for investors.
AI Enhances Emergency Room Efficiencyby Lilu Anderson 13.08.2024AI slashes ER patient wait times, boosting outcomes by prioritizing care.
Recursion Merges with Exscientia to Accelerate Drug Discoveryby Lilu Anderson 13.08.2024Recursion Pharmaceuticals merges with Exscientia to revolutionize drug discovery, bringing new treatments to market more quickly.
Amgen to Launch Tech and Innovation Hub in Indiaby Lilu Anderson 12.08.2024Amgen plans a new site in Hyderabad to boost digital capabilities and advance its medicine pipeline.
Legend Biotech’s Q2 2024 Earnings: Growth & Strategyby Lilu Anderson 12.08.2024Legend Biotech reports significant revenue growth in Q2 2024, with strategic advancements in CAR-T therapies.
AI Enhances ECG Interpretation, Speeds Treatmentby Lilu Anderson 10.08.2024Artificial intelligence in ECG analysis reduces door-to-balloon time, improving acute coronary syndrome patient outcomes.
Bitcoin Eyes $100K After Bullish Divergenceby John Darbie 10.08.2024Crypto analyst Svenson sees BTC rebounding, targets $100K after recent market dip, highlighting bullish patterns.
Bitcoin’s Decline: Opportunity or Risk?by John Darbie 09.08.2024Explore if Bitcoin's price drop is a buying opportunity amidst market volatility.